Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for ICLR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 9.378B
March 31, 2026 9.300B
December 31, 2025 9.193B
September 30, 2025 8.994B
June 30, 2025 9.501B
March 31, 2025 9.501B
December 31, 2024 9.441B
September 30, 2024 9.658B
June 30, 2024 9.453B
March 31, 2024 9.364B
December 31, 2023 9.241B
September 30, 2023 8.959B
June 30, 2023 8.796B
March 31, 2023 8.654B
December 31, 2022 8.498B
September 30, 2022 8.239B
June 30, 2022 8.146B
March 31, 2022 8.069B
December 31, 2021 8.067B
September 30, 2021 7.969B
June 30, 2021 2.028B
March 31, 2021 1.934B
December 31, 2020 1.850B
September 30, 2020 1.711B
June 30, 2020 1.578B
Date Value
March 31, 2020 1.514B
December 31, 2019 1.618B
September 30, 2019 1.502B
June 30, 2019 1.496B
March 31, 2019 1.422B
December 31, 2018 1.354B
September 30, 2018 1.334B
June 30, 2018 1.239B
March 31, 2018 1.205B
December 31, 2017 1.191B
September 30, 2017 1.128B
June 30, 2017 1.030B
March 31, 2017 944.51M
December 31, 2016 945.17M
September 30, 2016 991.86M
June 30, 2016 909.97M
March 31, 2016 843.68M
December 31, 2015 763.10M
September 30, 2015 863.27M
June 30, 2015 1.022B
March 31, 2015 999.27M
December 31, 2014 950.21M
September 30, 2014 1.011B
June 30, 2014 998.33M
March 31, 2014 960.78M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
IQVIA Holdings, Inc. 6.171B
Medpace Holdings, Inc. 433.86M
Proteome Sciences Plc --
Champions Oncology, Inc. 3.939M
Avantor, Inc. 5.630B

Shareholders Equity (Quarterly) Related Metrics